News

Scientists Create Cancer-Fighting Immune Cells Right in the Body

For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized facility where they’re genetically reprogrammed to fight cancer, then ship them back for infusion

Molecular Garbage on Tumors Makes Easy Target for Antibody Drugs

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor growth and stayed hidden from the immune system. But now researchers at UC San Francisco have

Drug Discovery, Biomarkers, and more at Prostate Cancer Symposium

In late February, the Feng Symposium on Prostate Cancer Revolutions in San Francisco brought together a community of researchers, clinicians, and innovators committed to accelerating treatments for patients with prostate cancer. The event continued the rich legacy of University of California, San

Protect Your Skin from UV Damage for as Little as $40 a Year 

Consumers can protect their skin from damaging ultraviolet (UV) light rays for as little as $40 a year — or as much as $1,400 a year — depending on how expensive a sunscreen they buy and how much of their skin they protect with hats and clothing, according to a new analysis by researchers at UC San

Eleven Cancer Research Projects Funded in Fall 2025 RAP Cycle

Eleven investigators and teams were awarded grants in support of cancer research projects in the fall 2025 cycle of the UCSF Resource Allocation Program (RAP). Funded by various agencies across UCSF, the awards span a range of topics from cancer patient navigation to molecular imaging to immune

Addressing Young-Onset Colorectal Cancer: Q&A with Dr. Chloe Atreya

Colorectal cancer is rising in adults under 50, and the trend is reshaping how we think about screening, stigma, and care. At UCSF, Drs. Chloe Atreya and Katherine Van Loon, both GI oncologists, are launching a new Young-Onset Colorectal Cancer Program designed to meet the distinct medical and life

Two New Breakthroughs Advance Neurological Disorders and Cancer Research

How does origami-like DNA affect brain development? How do cancer-immune cell interactions prevent immune cell activity in tumors? Two breakthrough discoveries by UC San Francisco scientists answer these questions and could open new paths to preventing and treating conditions such as autism and